Rapid Micro Biosystems, Inc.

NasdaqCM:RPID Stock Report

Market Cap: US$69.3m

Rapid Micro Biosystems Future Growth

Future criteria checks 1/6

Rapid Micro Biosystems is forecast to grow earnings and revenue by 17.1% and 18.4% per annum respectively while EPS is expected to grow by 17.2% per annum.

Key information

17.1%

Earnings growth rate

17.2%

EPS growth rate

Life Sciences earnings growth16.6%
Revenue growth rate18.4%
Future return on equityn/a
Analyst coverage

Low

Last updated04 Nov 2024

Recent future growth updates

Recent updates

Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Jan 16
Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Nov 02
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?

Oct 29
Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?

A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb

Aug 03
A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb

We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Jun 30
We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing

Oct 10

Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth

May 09
Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth

Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67

Mar 08
Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67

We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Feb 07
We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Earnings and Revenue Growth Forecasts

NasdaqCM:RPID - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202533-39N/AN/A2
12/31/202427-47N/AN/A2
9/30/202426-48-45-44N/A
6/30/202425-50-47-45N/A
3/31/202423-52-46-44N/A
12/31/202323-52-47-45N/A
9/30/202321-58-49-47N/A
6/30/202319-61-56-53N/A
3/31/202318-60-64-58N/A
12/31/202217-61-65-59N/A
9/30/202218-59-68-60N/A
6/30/202220-68-71-64N/A
3/31/202222-69-66-61N/A
12/31/202123-78-58-55N/A
9/30/202123-77-49-47N/A
6/30/202122-63-38-37N/A
3/31/202118-60-35-34N/A
12/31/202016-45-32-31N/A
12/31/201917-27-23-21N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RPID is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: RPID is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: RPID is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: RPID's revenue (18.4% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: RPID's revenue (18.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if RPID's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 09:54
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rapid Micro Biosystems, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tycho PetersonJ.P. Morgan
Tejas SavantMorgan Stanley
Daniel AriasStifel, Equities Research